Kevin Bowrin (K Bowrin)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Oral Anticoagulants

Peripheral Artery Disease

Top Venues

Cardiovascular therapeutics

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Olivia Wu, Stephen Morris, Torben Bjerregaard Larsen, Flemming Skjøth, Alex Evans, Kevin Bowrin, Piotr Wojciechowski, Wojciech Margas, Maria Huelsebeck
Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies. Cardiovascular therapeutics 2022 (2022)
Carina Blomström Lundqvist, Sara Själander, Luis Alberto García-Rodríguez, Örjan Åkerborg, Guanyi Jin, Amrit Caleyachetty, Maria Huelsebeck, Kevin Bowrin, Bernhard Schaefer, Hovsep Mahdessian, Lucas Hofmeister, Lars-Åke Levin
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis. Journal of medical economics 25 (1) (2022)
J A Spoorendonk, Jean-Baptiste Brière, Kevin Bowrin, A Millier, M Coppens, S Tempelaar, B Verheggen
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands. Journal of medical economics 24 (1) (2021)
Rupert M Bauersachs, Olivia Wu, Neil Hawkins, Kevin Bowrin, Piotr Wojciechowski, Emilie Clay, Maria Huelsebeck
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis. Cardiovascular therapeutics 2021 (2021)
Kevin Bowrin, Jean-Baptiste Briere, Laurent Fauchier, Craig Coleman, Aurélie Millier, Mondher Toumi, Emilie Clay, Pierre Levy
Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France. PloS one 15 (1) (2020)